Lead and direct national strategic accounts for Lexicon's Carcinoid Syndrome ultra-orphan therapeutic category. Responsibility includes business and clinical development and access in the plan and specialty pharmacy marketplace. Expertise includes successful business collaboration with government, IDN, and commercial accounts. Develop payer channel strategy for new product launches and execution of product commercialization. Work closely with HEOR, marketing, and sales for maximizing corporate goal attainment.

Led strategy and marketing for US Health Plans and PBMs in the Corporate and Government Customers (CGC) Business Unit. In this newly developed role and business model structure, responsibility included driving Health Plan and PBM channel strategy development across all Bayer US RX priority brands. Sought customer, competitive, market, program, and innovation information to form a comprehensive solution that aligned with the Bayer Brand strategies. Worked with brand teams, CGC contracting and marketing, LMR, HEOR, and legal departments to formulate and execute account plans that resulted in positive customer designed solutions. Therapeutic areas included MS, PAH, Hemophilia, Oncology, Womens' Health, and Dermatology.

Led the Managed Markets Department for Bayer's Dermatology Business Unit. Was US Headquarters leader, impacting national performance through product strategy and execution with Managed Markets customers. Reported to President of Business Unit, with ultimate reporting responsibility to Global Headquarters in Berlin. As influential cross-functional advocate, collaborated with Finance, Sales, Marketing, Medical Affairs, Regulatory, Product Development, Legal, and Market Research. Led team of six that covered National and Regional customers, including Commercial health plans, Medicaid, Medicare, GPOs, PBMs, mail-order, trade, government, and large employers. Was responsible for driving profitable operations through contract negotiation, cross-functional and departmental collaboration, and CRM.Awards and Recognitions:Platinum Award for Excellence in Managed Markets launch development for Finacea FoamPlatinum Award in the "Better Because of You" Bayer recognition program for LeadershipSelected for "Women's Leadership Peer Coaching Program" during first year Selected by Executive Committee to attend the Bayer Business Management Program at University of Notre Dame's Mendoza College of BusinessPresented at CBI's June 2013 Managed Market Strategy Conference in Philadelphia, PASelected for Pharmacy Times Industry Roundtable Discussion Advisory Board in August 2013

During the transitional time frame until returning to pharmaceuticals, I consulted with non-profit organizations to develop strategic business and marketing plans for increased revenue and operational solutions. Worked with their internal staffs to help create cost savings and operational efficiencies. Utilized Lean Six Sigma techniques to maximize and streamline departmental structure. Clients included St. Vincent de Paul, Christian Community Action, and the American Diabetes Association, Dallas. During the consultation with American Diabetes, I worked on Media and Public Relations for the "Stars of Texas...Racing Against the Odds" fundraiser, and increased media exposure by 100%. The event raised $350,000, which was higher than all previous years.

Developed business relationships with Executive Management in priority TX Managed Markets organizations for contracting, negotiations, formulary design, and disease management initiatives. Accounts included Medicaid, Medicare, Commercial, Employer, and GPO. Utilized critical thinking skills and worked closely with cross-functional teams for pull-through and product launches. Prepared forecasting and analysis reports for account strategies. Increased preferred formulary access for cardiovascular, allergy, respiratory, hepatitis C, anti-infective, anti-psychotic, oncology, dermatology, and women's health products. Drove approximately $200 million in account revenues (47% of South Central Region's Managed Markets performance). Led National "Cardiovascular Team-Up" Markets to numbers #1 and #2 in nation for 18 months. Created innovative disease management and training programs for managed care accounts and employers. Developed and directed Texas "Team Avelox" Program to drive market share across multiple divisions. Created Managed Markets training presentation for use with medical professionals. Developed disease management and e-health initiatives for large patient populations. Received the following awards:Shining Performance, from CEO Fred Hassan, for "Outstanding Contributions to the Organization"Envision Award, for "Active Account Management Execution"President's Award, for being #1/7 for Managed Markets National Performance"Run Through the Warehouse" Award for Clarinex National Market Share Performance"Own It, Grow It, Grab It" Award for Hepatitis C Product Performance

Led and developed 15 - person sales team in six state district that included MN, ND, SD, NE, IA, and WI. Therapy areas included cardiovascular, allergy, and respiratory products. Took district that was ranked 29/37 to 6/37 in 2.5 years. Received KOSMC Award for Outstanding National District Performance.

Was promoted to newly created rotational marketing position utilizing $3 million sales promotional budget. Designed and implemented innovative managed care marketing programs for a Managed Markets team that included approximately 200 field and headquarter personnel. Collaborated with sales, marketing, and finance to develop programs for field contracting and product commercialization. Collaborated with think tanks and speaker's bureaus for corporate conferences, both domestically and internationally. Developed annual Managed Markets international CEO conference in Madrid, Spain, and Managed Markets Directors' conference in San Antonio, TX. Both conferences included cutting-edge presentations from national and international content experts.